Skip to main content

Three risk management strategies for expedited approvals

In this video, Alberto Grignolo discusses the dilemma of innovation vs. the affordability of novel treatments and outlines three risk management strategies for drug developers who wish to take full advantage of expedited pathways to achieve reimbursable innovation for the benefit of patients.